A clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases a autoimmune disorders. We believe our ability to discover and develop differentiated product candidates in an efficient manner allows us to address well-established multi-billion-dollar commercial markets and positions us to become a leader in the immunology market.
Lead Underwriter
Evercore Group L.L.C, Jefferies LLC, Piper Sandler & Co
